In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health Applications
Growing evidence supports the use of nitrate-reducing bacterial strains as probiotics to enhance the benefits of nitrate metabolism for both oral and systemic health. This study aimed to test the nitrate reductase activity of <i>Levilactobacillus brevis</i> CD2 (DSM-27961/CNCM I-5566), a...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Foods |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2304-8158/14/9/1512 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850030398231281664 |
|---|---|
| author | Serena Altamura Francesca Rosaria Augello Francesca Lombardi Paola Palumbo Benedetta Cinque Davide Pietropaoli Claudio De Simone |
| author_facet | Serena Altamura Francesca Rosaria Augello Francesca Lombardi Paola Palumbo Benedetta Cinque Davide Pietropaoli Claudio De Simone |
| author_sort | Serena Altamura |
| collection | DOAJ |
| description | Growing evidence supports the use of nitrate-reducing bacterial strains as probiotics to enhance the benefits of nitrate metabolism for both oral and systemic health. This study aimed to test the nitrate reductase activity of <i>Levilactobacillus brevis</i> CD2 (DSM-27961/CNCM I-5566), a strain widely used as a starter culture in fermented foods and recognized for its multifaceted health-promoting probiotic properties. We also sought to determine whether the probiotic lysate enhances nitrate reduction ex vivo using six salivary samples from healthy subjects while evaluating its potential influence on pH and buffering capacity. Considering the established link between lactate metabolism and nitrite production, we assessed the salivary levels of D-lactate after a 3-hour incubation with or without <i>Lv. brevis</i>. The results indicate that <i>Lv. brevis</i> CD2 exhibits significant intrinsic and concentration-dependent nitrate reductase activity. Additionally, treatment with <i>Lv. brevis</i> for 3 h significantly increased nitrite generation across all saliva samples, with further enhancement observed after the addition of exogenous nitrates. <i>Lv. brevis</i> also significantly improved salivary pH and buffering capacity, particularly when combined with nitrate. Furthermore, the probiotic treatment resulted in reduced levels of salivary D-lactate. To further support and validate our in vitro and ex vivo findings, we evaluated the oral nitrate-reducing activity in saliva samples from healthy individuals treated for four weeks with <i>Lv. brevis</i> CD2 lozenges. Of note, the results indicated that the probiotic group showed a significant increase in oral nitrate-reducing capacity compared to baseline and placebo after four weeks of treatment. Overall, our study suggests that <i>Lv. brevis</i> CD2 acts as a nitrate-reducing probiotic, providing new insights into its health benefits and complementing findings from previous studies. |
| format | Article |
| id | doaj-art-0a7ad0847e724745a7de8e7fc6f5d463 |
| institution | DOAJ |
| issn | 2304-8158 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Foods |
| spelling | doaj-art-0a7ad0847e724745a7de8e7fc6f5d4632025-08-20T02:59:14ZengMDPI AGFoods2304-81582025-04-01149151210.3390/foods14091512In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health ApplicationsSerena Altamura0Francesca Rosaria Augello1Francesca Lombardi2Paola Palumbo3Benedetta Cinque4Davide Pietropaoli5Claudio De Simone6Department of Life, Health & Environmental Sciences, University of L’Aquila, 67100 L’Aquila, ItalyDepartment of Life, Health & Environmental Sciences, University of L’Aquila, 67100 L’Aquila, ItalyDepartment of Life, Health & Environmental Sciences, University of L’Aquila, 67100 L’Aquila, ItalyDepartment of Life, Health & Environmental Sciences, University of L’Aquila, 67100 L’Aquila, ItalyDepartment of Life, Health & Environmental Sciences, University of L’Aquila, 67100 L’Aquila, ItalyDepartment of Physical and Chemical Sciences, University of L’Aquila, 67100 L’Aquila, ItalyRetired Professor of Infectious Diseases at the University of L’Aquila, 67100 L’Aquila, ItalyGrowing evidence supports the use of nitrate-reducing bacterial strains as probiotics to enhance the benefits of nitrate metabolism for both oral and systemic health. This study aimed to test the nitrate reductase activity of <i>Levilactobacillus brevis</i> CD2 (DSM-27961/CNCM I-5566), a strain widely used as a starter culture in fermented foods and recognized for its multifaceted health-promoting probiotic properties. We also sought to determine whether the probiotic lysate enhances nitrate reduction ex vivo using six salivary samples from healthy subjects while evaluating its potential influence on pH and buffering capacity. Considering the established link between lactate metabolism and nitrite production, we assessed the salivary levels of D-lactate after a 3-hour incubation with or without <i>Lv. brevis</i>. The results indicate that <i>Lv. brevis</i> CD2 exhibits significant intrinsic and concentration-dependent nitrate reductase activity. Additionally, treatment with <i>Lv. brevis</i> for 3 h significantly increased nitrite generation across all saliva samples, with further enhancement observed after the addition of exogenous nitrates. <i>Lv. brevis</i> also significantly improved salivary pH and buffering capacity, particularly when combined with nitrate. Furthermore, the probiotic treatment resulted in reduced levels of salivary D-lactate. To further support and validate our in vitro and ex vivo findings, we evaluated the oral nitrate-reducing activity in saliva samples from healthy individuals treated for four weeks with <i>Lv. brevis</i> CD2 lozenges. Of note, the results indicated that the probiotic group showed a significant increase in oral nitrate-reducing capacity compared to baseline and placebo after four weeks of treatment. Overall, our study suggests that <i>Lv. brevis</i> CD2 acts as a nitrate-reducing probiotic, providing new insights into its health benefits and complementing findings from previous studies.https://www.mdpi.com/2304-8158/14/9/1512lactic acid bacteriaprobiotics<i>Levilactobacillus brevis</i> CD2nitrate reductaseoral and systemic health |
| spellingShingle | Serena Altamura Francesca Rosaria Augello Francesca Lombardi Paola Palumbo Benedetta Cinque Davide Pietropaoli Claudio De Simone In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health Applications Foods lactic acid bacteria probiotics <i>Levilactobacillus brevis</i> CD2 nitrate reductase oral and systemic health |
| title | In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health Applications |
| title_full | In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health Applications |
| title_fullStr | In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health Applications |
| title_full_unstemmed | In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health Applications |
| title_short | In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in <i>Levilactobacillus brevis</i> CD2: A Potential Tool for Oral and Systemic Health Applications |
| title_sort | in vitro ex vivo and in vivo evidence of nitrate reducing activity in i levilactobacillus brevis i cd2 a potential tool for oral and systemic health applications |
| topic | lactic acid bacteria probiotics <i>Levilactobacillus brevis</i> CD2 nitrate reductase oral and systemic health |
| url | https://www.mdpi.com/2304-8158/14/9/1512 |
| work_keys_str_mv | AT serenaaltamura invitroexvivoandinvivoevidenceofnitratereducingactivityinilevilactobacillusbrevisicd2apotentialtoolfororalandsystemichealthapplications AT francescarosariaaugello invitroexvivoandinvivoevidenceofnitratereducingactivityinilevilactobacillusbrevisicd2apotentialtoolfororalandsystemichealthapplications AT francescalombardi invitroexvivoandinvivoevidenceofnitratereducingactivityinilevilactobacillusbrevisicd2apotentialtoolfororalandsystemichealthapplications AT paolapalumbo invitroexvivoandinvivoevidenceofnitratereducingactivityinilevilactobacillusbrevisicd2apotentialtoolfororalandsystemichealthapplications AT benedettacinque invitroexvivoandinvivoevidenceofnitratereducingactivityinilevilactobacillusbrevisicd2apotentialtoolfororalandsystemichealthapplications AT davidepietropaoli invitroexvivoandinvivoevidenceofnitratereducingactivityinilevilactobacillusbrevisicd2apotentialtoolfororalandsystemichealthapplications AT claudiodesimone invitroexvivoandinvivoevidenceofnitratereducingactivityinilevilactobacillusbrevisicd2apotentialtoolfororalandsystemichealthapplications |